Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127192381 | 12719238 | 1 | I | 20160825 | 20160907 | 20160907 | EXP | CN-TAKEDA-2016MPI007756 | TAKEDA | BAO L, LU X, ZHANG X, ZHANG Y, ZHU H, HUANG X.. BORTEZOMIB-BASED COMBINATION THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA.. CHIN J INTER MED. 2008;47(2):107-110 | 0.00 | Y | 0.00000 | 20160906 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127192381 | 12719238 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.3 MG/M2, UNK | Y | 21602 | 1.3 | MG/M**2 | INJECTION | ||||||
127192381 | 12719238 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | 1 MG/M2, UNK | Y | 21602 | 1 | MG/M**2 | INJECTION | ||||||
127192381 | 12719238 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
127192381 | 12719238 | 4 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127192381 | 12719238 | 1 | Plasma cell myeloma |
127192381 | 12719238 | 3 | Plasma cell myeloma |
127192381 | 12719238 | 4 | Plasma cell myeloma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127192381 | 12719238 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127192381 | 12719238 | Abdominal pain upper | |
127192381 | 12719238 | Abdominal rigidity | |
127192381 | 12719238 | Constipation | |
127192381 | 12719238 | Decreased appetite | |
127192381 | 12719238 | Diarrhoea | |
127192381 | 12719238 | Herpes zoster | |
127192381 | 12719238 | Infection | |
127192381 | 12719238 | Insomnia | |
127192381 | 12719238 | Nausea | |
127192381 | 12719238 | Neuropathy peripheral | |
127192381 | 12719238 | Neurotoxicity | |
127192381 | 12719238 | Neutrophil count decreased | |
127192381 | 12719238 | Platelet count decreased | |
127192381 | 12719238 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |